Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2016040527242N1Phase 3Completed
Phase 3 trial of pethidine, sponsored by Sabzevar University of Medical Sciences. Primary endpoint: Incidence of post–spinal anesthesia shivering. Started Jul 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2016040527242N1.